+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical and electrophysiological characteristics of chronic inflammatory demyelinating polyneuropathy , CIDP with monoclonal gammopathy of uncertain significance and demyelinating neuropathy with antibodies to myelin associated glycoprotein



Clinical and electrophysiological characteristics of chronic inflammatory demyelinating polyneuropathy , CIDP with monoclonal gammopathy of uncertain significance and demyelinating neuropathy with antibodies to myelin associated glycoprotein



Neurology 50(4 Suppl. 4): A145




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030556248

Download citation: RISBibTeXText


Related references

Nerve conduction studies in chronic inflammatory demyelinating polyradiculoneuropathy cidp in patients with and without an associated monoclonal gammopathy of uncertain significance mgus. Neurology 41(3 Suppl. 1): 250, 1991

Comparison of monoclonal gammopathy of undetermined significance-associated neuropathy and chronic inflammatory demyelinating polyneuropathy patients. Journal of Neurology 261(8): 1485-1491, 2014

Intravenous immunoglobulins ivig treatment of igg k monoclonal gammopathy of undetermined significance mgus associated chronic inflammatory demyelinating polyradiculoneuropathy cidp. Imbach, P (Ed ) Immunotherapy With Intravenous Immunoglobulins; Conference, Interlaken, Switzerland, May 6-9, 1990 Xx+484p Academic Press Ltd : London, England, Uk; San Diego, California, Usa Illus 468, 1991

Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy and in neuropathy associated with IgM monoclonal gammopathy of unknown significance. Neurology 40(2): 327-328, 1990

Comparison of patients with idiopathic chronic inflammatory demyelinating polyradiculoneuropathy and CIDP-associated with monoclonal gammopathy. Neurology 46(2 Suppl. ): A209, 1996

Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 48(2): 321-328, 1997

Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle and Nerve 41(2): 202-207, 2010

CD5+ B cells secreting anti-peripheral nerve myelin antibodies in patients with monoclonal gammopathy and demyelinating polyneuropathy. Journal of Neuroimmunology 54(1-2): 157, 1994

Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP). Journal of Neuropathology and Experimental Neurology 56(7): 811-821, 1997

Clinical condition of chronic inflammatory demyelinating polyneuropathy (CIDP). Muscle and Nerve 39(4): V-Vii, 2009

High titer serum anti tubulin antibodies are a marker for chronic inflammatory demyelinating polyneuropathy cidp. Neurology 42(4 Suppl. 3): 409, 1992

Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg). Journal of Neuroimmunology 54(1-2): 109-115, 1994

Chronic inflammatory demyelinating polyneuropathy: multifocal demyelinating neuropathy. No to Shinkei 44(8): 709-718, 1992

The range of chronic demyelinating neuropathy of infancy From Dejerine-Sottas disease to acquired inflammatory demyelinating polyneuropathy. Neurology 52(6 Suppl. 2): A85, 1999

Passive transfer studies in demyelinating neuropathy with IgM monoclonal antibodies to myelin-associated glycoprotein. Journal of Neurology Neurosurgery and Psychiatry 48(9): 927-929, 1985